[Neuraminidase inhibitor].

M, Kaji

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2001

Data sources: Europe PubMed Central

[Neuraminidase inhibitor].

descriptionPublicationkeyboard_double_arrow_right Article 10 May 2001 Japanese Journal:Nihon rinsho. Japanese journal of clinical medicine, volume 58 (issn: 0047-1852,

Copyright policy )

Authors: M, Kaji;

pmid: 11225320

[Neuraminidase inhibitor].

- Summary
- Subjects
- Metrics

Abstract

Amantadine, effective to influenza A virus, is now widely used in Japan. Recently new anti-influenzal agents, neuramidase inhibitor has been developed. Both Zanamivir (inhaled type) and Oseltamivir(oral use), are proved to be effective in treatment of influenza A and B. Mechanism of action on influenza virus, dosage, side effects of the anti-influenza agents are described. Clinicians expect to medicate to influenza with the agents as soon as possible.

Related Organizations

Kurume University Medical Center
Japan

Keywords

Neuraminidase, Antiviral Agents, Guanidines, Influenza B virus, Oseltamivir, Influenza A virus, Acetamides, Influenza, Human, Sialic Acids, Humans, Zanamivir, Enzyme Inhibitors, Pyrans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average